These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17199719)

  • 41. Lipogenesis in genetically diabetic (db/db) mice: developmental changes in brown adipose tissue, white adipose tissue and the liver.
    Trayhurn P; Wusteman MC
    Biochim Biophys Acta; 1990 Nov; 1047(2):168-74. PubMed ID: 2248973
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Whole body hyperthermia improves obesity-induced insulin resistance in diabetic mice.
    Kokura S; Adachi S; Manabe E; Mizushima K; Hattori T; Okuda T; Nakabe N; Handa O; Takagi T; Naito Y; Yoshida N; Yoshikawa T
    Int J Hyperthermia; 2007 May; 23(3):259-65. PubMed ID: 17523018
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reduced adiposity and improved insulin sensitivity in obese mice with antisense suppression of 4E-BP2 expression.
    Yu XX; Pandey SK; Booten SL; Murray SF; Monia BP; Bhanot S
    Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E530-9. PubMed ID: 18198353
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of oral hypoglycemic drugs on heart norepinephrine (NE) in rats and mice.
    Anton AH; Berk AI
    Res Commun Chem Pathol Pharmacol; 1982 Jan; 35(1):79-94. PubMed ID: 7058290
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.
    Hong EG; Jung DY; Ko HJ; Zhang Z; Ma Z; Jun JY; Kim JH; Sumner AD; Vary TC; Gardner TW; Bronson SK; Kim JK
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1687-96. PubMed ID: 17911348
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum brain-derived neurotrophic factor in patients with type 2 diabetes mellitus: Relationship to glucose metabolism and biomarkers of insulin resistance.
    Fujinami A; Ohta K; Obayashi H; Fukui M; Hasegawa G; Nakamura N; Kozai H; Imai S; Ohta M
    Clin Biochem; 2008 Jul; 41(10-11):812-7. PubMed ID: 18402781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Supplementation with branched-chain amino acids inhibits azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice.
    Shimizu M; Shirakami Y; Iwasa J; Shiraki M; Yasuda Y; Hata K; Hirose Y; Tsurumi H; Tanaka T; Moriwaki H
    Clin Cancer Res; 2009 May; 15(9):3068-75. PubMed ID: 19366832
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transgenic expression of a mutated cyclin-dependent kinase 4 (CDK4/R24C) in pancreatic beta-cells prevents progression of diabetes in db/db mice.
    Miyawaki K; Inoue H; Keshavarz P; Mizuta K; Sato A; Sakamoto Y; Moritani M; Kunika K; Tanahashi T; Itakura M
    Diabetes Res Clin Pract; 2008 Oct; 82(1):33-41. PubMed ID: 18678431
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Variable onset determinants and consequences of diabetes (db/db) obesity mutation expression: adrenergic promotion of utero-ovarian dysfunction.
    Garris DR
    Horm Metab Res; 2004 May; 36(5):312-8. PubMed ID: 15156412
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of a cachectic factor on carbohydrate metabolism and attenuation by eicosapentaenoic acid.
    Hussey HJ; Tisdale MJ
    Br J Cancer; 1999 Jun; 80(8):1231-5. PubMed ID: 10376976
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional significance of skeletal muscle adiponectin production, changes in animal models of obesity and diabetes, and regulation by rosiglitazone treatment.
    Liu Y; Chewchuk S; Lavigne C; Brûlé S; Pilon G; Houde V; Xu A; Marette A; Sweeney G
    Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E657-64. PubMed ID: 19531641
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of docosahexaenoic acid on tissue targeting and metabolism of plasma lipoproteins.
    Polozova A; Gionfriddo E; Salem N
    Prostaglandins Leukot Essent Fatty Acids; 2006 Sep; 75(3):183-90. PubMed ID: 16837179
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intermittent administration of brain-derived neurotrophic factor ameliorates glucose metabolism in obese diabetic mice.
    Ono M; Itakura Y; Nonomura T; Nakagawa T; Nakayama C; Taiji M; Noguchi H
    Metabolism; 2000 Jan; 49(1):129-33. PubMed ID: 10647076
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
    Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
    Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Monoclonal antibody against brain derived neurotrophic factor inhibits myeloma growth and angiogenesis in the xenograft NOD/SCID animal model].
    Wang YD; Hu Y; Zhang L; Huang J; Sun CY
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):659-63. PubMed ID: 18399169
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fibroblast growth factor 21 analogue LY2405319 lowers blood glucose in streptozotocin-induced insulin-deficient diabetic mice by restoring brown adipose tissue function.
    Kim JH; Bae KH; Choi YK; Go Y; Choe M; Jeon YH; Lee HW; Koo SH; Perfield JW; Harris RA; Lee IK; Park KG
    Diabetes Obes Metab; 2015 Feb; 17(2):161-9. PubMed ID: 25359298
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Music exposure differentially alters the levels of brain-derived neurotrophic factor and nerve growth factor in the mouse hypothalamus.
    Angelucci F; Ricci E; Padua L; Sabino A; Tonali PA
    Neurosci Lett; 2007 Dec; 429(2-3):152-5. PubMed ID: 17980967
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolism of palmitate-1-14C in the tissues of rats with streptozotocin diabetes.
    Chorváthová V; Ondreicka R; Ozdin L; Dzúrik R
    Physiol Bohemoslov; 1981; 30(3):259-66. PubMed ID: 6455683
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulin response in individual tissues of control and gold thioglucose-obese mice in vivo with [1-14C]2-deoxyglucose.
    Cooney GJ; Astbury LD; Williams PF; Caterson ID
    Diabetes; 1987 Feb; 36(2):152-8. PubMed ID: 3100366
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impairment of cell-mediated immunity in mutation diabetic mice (db/db).
    Mandel MA; Mahmoud AA
    J Immunol; 1978 Apr; 120(4):1375-7. PubMed ID: 347001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.